S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
NASDAQ:TMCI

Treace Medical Concepts (TMCI) Stock Price, News & Analysis

$11.40
-0.13 (-1.13%)
(As of 04/17/2024 ET)
Today's Range
$11.27
$11.76
50-Day Range
$11.40
$15.86
52-Week Range
$5.27
$27.70
Volume
319,345 shs
Average Volume
485,659 shs
Market Capitalization
$704.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.58

Treace Medical Concepts MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
71.8% Upside
$19.58 Price Target
Short Interest
Healthy
6.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.55mentions of Treace Medical Concepts in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.91) to ($0.79) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.75 out of 5 stars

Medical Sector

405th out of 913 stocks

Surgical & Medical Instruments Industry

41st out of 89 stocks

TMCI stock logo

About Treace Medical Concepts Stock (NASDAQ:TMCI)

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

TMCI Stock Price History

TMCI Stock News Headlines

Treace Announces First Annual National Bunion Day
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
7 Stable Stocks for 50% Returns by Early 2025
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Down 5.2%
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
Treace Medical Concepts Inc
TMCI Sep 2024 20.000 call
TMCI Jun 2024 22.500 call
TMCI Mar 2024 17.500 call
TMCI Mar 2024 25.000 call
Treace Medical Concepts Inc (TMCI)
See More Headlines
Receive TMCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/17/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:TMCI
Fax
N/A
Employees
516
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.58
High Stock Price Target
$27.50
Low Stock Price Target
$11.00
Potential Upside/Downside
+71.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-49,530,000.00
Pretax Margin
-26.47%

Debt

Sales & Book Value

Annual Sales
$187.12 million
Book Value
$2.24 per share

Miscellaneous

Free Float
46,668,000
Market Cap
$704.06 million
Optionable
Optionable
Beta
0.27
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. John T. TreaceMr. John T. Treace (Age 52)
    CEO, Founder & Director
    Comp: $1.09M
  • Mr. Mark L. Hair CPA (Age 54)
    Chief Financial Officer
    Comp: $599.7k
  • Mr. Aaron J. Berutti (Age 45)
    Senior Vice President of Sales
    Comp: $484.22k
  • Mr. Terry W. Lubben (Age 59)
    Senior Vice President of Operations
  • Ms. Julie D. Dewey (Age 63)
    Chief Communications & Investor Relations Officer
  • Mr. Scot M. Elder J.D. (Age 49)
    Chief Legal & Compliance Officer and Corporate Secretary
  • Mr. Nathan Minnich
    Senior Vice President of Marketing
  • Mr. Daniel E. Owens (Age 52)
    Chief Human Resources Officer
  • Dr. Sean F. Scanlan Ph.D. (Age 42)
    Chief Innovation Officer
  • Ms. Shana Zink
    Senior Vice President of Clinical Affairs, Medical Education & Reimbursement

TMCI Stock Analysis - Frequently Asked Questions

Should I buy or sell Treace Medical Concepts stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Treace Medical Concepts in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TMCI shares.
View TMCI analyst ratings
or view top-rated stocks.

What is Treace Medical Concepts' stock price target for 2024?

6 brokerages have issued 1 year price targets for Treace Medical Concepts' stock. Their TMCI share price targets range from $11.00 to $27.50. On average, they predict the company's stock price to reach $19.58 in the next twelve months. This suggests a possible upside of 71.8% from the stock's current price.
View analysts price targets for TMCI
or view top-rated stocks among Wall Street analysts.

How have TMCI shares performed in 2024?

Treace Medical Concepts' stock was trading at $12.75 at the beginning of 2024. Since then, TMCI shares have decreased by 10.6% and is now trading at $11.40.
View the best growth stocks for 2024 here
.

When is Treace Medical Concepts' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our TMCI earnings forecast
.

How can I listen to Treace Medical Concepts' earnings call?

Treace Medical Concepts will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Treace Medical Concepts' earnings last quarter?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) posted its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.01. The firm had revenue of $62.20 million for the quarter, compared to the consensus estimate of $60.56 million. Treace Medical Concepts had a negative net margin of 26.47% and a negative trailing twelve-month return on equity of 33.96%. The firm's revenue for the quarter was up 24.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.08) EPS.

What guidance has Treace Medical Concepts issued on next quarter's earnings?

Treace Medical Concepts issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $220.0 million-$225.0 million, compared to the consensus revenue estimate of $223.2 million.

When did Treace Medical Concepts IPO?

Treace Medical Concepts (TMCI) raised $150 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 9,400,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Treace Medical Concepts' major shareholders?

Treace Medical Concepts' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wealth Enhancement Advisory Services LLC (0.39%). Insiders that own company stock include Aaron Berutti, Daniel E Owens, F Barry Bays, Jaime A Frias, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben and Thomas E Timbie.
View institutional ownership trends
.

How do I buy shares of Treace Medical Concepts?

Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TMCI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners